Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Heartflow announced one-year results from the independent FUSION trial showing its FFRCT Analysis reduced unnecessary invasive heart procedures by 44% when added to standard CCTA scans. The Dutch government-funded randomized controlled trial of 528 patients demonstrated that Heartflow's AI technology safely bridges diagnostic gaps in coronary artery disease evaluation, maintaining identical revascularization rates while significantly reducing diagnostic catheterizations.